The National Cancer Institute (NCI) is offering a grant to support preliminary evaluation of the safety and efficacy of imaging agents, systems, and image-guided therapies in cancer patients. This grant aims to fund pilot clinical trials (Phase I and II) focusing on innovative uses of existing clinical imaging tools, as well as the exploration of new agents, systems, or methods. Successful investigations from these early trials may lead to further validation through larger studies supported by competitive R01 mechanisms or specialized cancer research programs.
Opportunity ID: 253109
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | PAR-14-166 |
Funding Opportunity Title: | Early Phase Clinical Trials in Imaging and Image-Guided Interventions (R01) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Education Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.394 — Cancer Detection and Diagnosis Research |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Mar 28, 2014 |
Last Updated Date: | – |
Original Closing Date for Applications: | Feb 09, 2017 |
Current Closing Date for Applications: | Feb 09, 2017 |
Archive Date: | Mar 12, 2017 |
Estimated Total Program Funding: | – |
Award Ceiling: | $250,000 |
Award Floor: | – |
Eligibility
Eligible Applicants: | Independent school districts Small businesses Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) County governments State governments City or township governments Public housing authorities/Indian housing authorities Private institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) For profit organizations other than small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | This Funding Opportunity Announcement (FOA) is intended to support clinical trials conducting preliminary evaluation of the safety and efficacy of imaging agents, as well as an assessment of imaging systems, image processing, image-guided therapy, contrast kinetic modeling, 3-D reconstruction and other quantitative tools. As many such preliminary evaluations are early in development, this FOA will provide investigators with support for pilot (Phase I and II) cancer imaging clinical trials, including patient monitoring and laboratory studies. This FOA supports novel uses of known/standard clinical imaging agents and methods as well as the evaluation of new agents, systems, or methods. The imaging and image-guided intervention (IGI) investigations, if proven successful in these early clinical trials, can then be validated in larger studies through competitive R01 mechanisms, or through clinical trials in the Specialized Programs of Research Excellence (SPOREs), Cancer Centers and/or the NCI’s National Clinical Trials Network. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-14-166.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-C | Forms-C | PKG00194483 | May 30, 2014 | Apr 02, 2016 | View | |
FORMS-D | Use for due dates on or after May 25, 2016 | PKG00222261 | May 09, 2016 | Feb 09, 2017 | View |
Package 1
Mandatory forms
253109 RR_SF424_2_0-2.0.pdf
253109 PHS398_ResearchPlan_2_0-2.0.pdf
253109 PHS398_CoverPageSupplement_2_0-2.0.pdf
253109 RR_KeyPersonExpanded_2_0-2.0.pdf
253109 RR_OtherProjectInfo_1_3-1.3.pdf
253109 PerformanceSite_2_0-2.0.pdf
Optional forms
253109 RR_SubawardBudget30_1_3-1.3.pdf
253109 PlannedReport-1.0.pdf
253109 PHS398_CumulativeInclusionReport-1.0.pdf
253109 PHS398_ModularBudget_1_2-1.2.pdf
253109 RR_Budget_1_3-1.3.pdf
Package 2
Mandatory forms
253109 RR_SF424_2_0-2.0.pdf
253109 PHS398_CoverPageSupplement_3_0-3.0.pdf
253109 RR_OtherProjectInfo_1_3-1.3.pdf
253109 PerformanceSite_2_0-2.0.pdf
253109 RR_KeyPersonExpanded_2_0-2.0.pdf
253109 PHS398_ResearchPlan_3_0-3.0.pdf
Optional forms
253109 RR_Budget_1_3-1.3.pdf
253109 RR_SubawardBudget30_1_3-1.3.pdf
253109 PHS398_ModularBudget_1_2-1.2.pdf
253109 PHS_Inclusion_Enrollment_Report-1.0.pdf
253109 PHS_AssignmentRequestForm-1.0.pdf